These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29137292)

  • 1. The clinical significance of
    Ma X; Wu Y; Zhang T; Song H; Jv H; Guo W; Ren G
    Oncotarget; 2017 Oct; 8(47):82661-82673. PubMed ID: 29137292
    [No Abstract]   [Full Text] [Related]  

  • 2. Ki67 Proliferation Index as a Histopathological Predictive and Prognostic Parameter of Oral Mucosal Melanoma in Patients without Distant Metastases.
    Ma X; Wu Y; Zhang T; Song H; Jv H; Guo W; Ren G
    J Cancer; 2017; 8(18):3828-3837. PubMed ID: 29151970
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel somatic KIT exon 8 mutation with dramatic response to imatinib in a patient with mucosal melanoma: a case report.
    Rapisuwon S; Parks K; Al-Refaie W; Atkins MB
    Melanoma Res; 2014 Oct; 24(5):509-11. PubMed ID: 25003536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.
    Ashida A; Takata M; Murata H; Kido K; Saida T
    Int J Cancer; 2009 Feb; 124(4):862-8. PubMed ID: 19035443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression.
    Bowlt Blacklock KL; Birand Z; Selmic LE; Nelissen P; Murphy S; Blackwood L; Bass J; McKay J; Fox R; Beaver S; Starkey M
    Sci Rep; 2019 Apr; 9(1):6511. PubMed ID: 31019223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRAS and BRAF mutation frequency in primary oral mucosal melanoma.
    Buery RR; Siar CH; Katase N; Gunduz M; Lefeuvre M; Fujii M; Inoue M; Setsu K; Nagatsuka H
    Oncol Rep; 2011 Oct; 26(4):783-7. PubMed ID: 21750866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neck dissection for oral mucosal melanoma: caution of nodular lesion.
    Wu Y; Zhong Y; Li C; Song H; Guo W; Ren G
    Oral Oncol; 2014 Apr; 50(4):319-24. PubMed ID: 24548569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
    Antonescu CR; Busam KJ; Francone TD; Wong GC; Guo T; Agaram NP; Besmer P; Jungbluth A; Gimbel M; Chen CT; Veach D; Clarkson BD; Paty PB; Weiser MR
    Int J Cancer; 2007 Jul; 121(2):257-64. PubMed ID: 17372901
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Chen F; Zhang Q; Wang Y; Wang S; Feng S; Qi L; Li X; Ding C
    Oncol Lett; 2018 Jun; 15(6):9786-9792. PubMed ID: 29805686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIT gene mutations and copy number in melanoma subtypes.
    Beadling C; Jacobson-Dunlop E; Hodi FS; Le C; Warrick A; Patterson J; Town A; Harlow A; Cruz F; Azar S; Rubin BP; Muller S; West R; Heinrich MC; Corless CL
    Clin Cancer Res; 2008 Nov; 14(21):6821-8. PubMed ID: 18980976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of KIT-mutated metastatic mucosal melanoma.
    Kim KB; Alrwas A
    Chin Clin Oncol; 2014 Sep; 3(3):35. PubMed ID: 25841461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib targeting of KIT-mutant oncoprotein in melanoma.
    Jiang X; Zhou J; Yuen NK; Corless CL; Heinrich MC; Fletcher JA; Demetri GD; Widlund HR; Fisher DE; Hodi FS
    Clin Cancer Res; 2008 Dec; 14(23):7726-32. PubMed ID: 19047099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors.
    Papaspyrou G; Garbe C; Schadendorf D; Werner JA; Hauschild A; Egberts F
    Melanoma Res; 2011 Dec; 21(6):475-82. PubMed ID: 21897303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
    Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
    Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib.
    Dai J; Kong Y; Si L; Chi Z; Cui C; Sheng X; Mao L; Li S; Lian B; Yang R; Liu S; Xu X; Guo J
    Clin Cancer Res; 2013 Dec; 19(24):6935-42. PubMed ID: 24132921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature.
    Satzger I; Küttler U; Völker B; Schenck F; Kapp A; Gutzmer R
    Dermatology; 2010; 220(1):77-81. PubMed ID: 19996579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive vitiligo associated to response to c-kit inhibitor in metastatic mucosal melanoma.
    Pala L; Conforti F; Cocorocchio E; Ferrucci PF
    Anticancer Drugs; 2020 Jul; 31(6):652-654. PubMed ID: 32011367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
    Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
    Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with avapritinib in patient with mucosal metastatic melanoma.
    Cocorocchio E; Pala L; Conforti F; Guerini-Rocco E; De Pas T; Ferrucci PF
    Ther Adv Med Oncol; 2020; 12():1758835920946158. PubMed ID: 32821296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of S628N: a novel KIT mutation found in a metastatic melanoma.
    Vita M; Tisserand JC; Chauvot de Beauchêne I; Panel N; Tchertanov L; Agopian J; Mescam-Mancini L; Fouet B; Fournier B; Dubreuil P; Bertucci F; De Sepulveda P
    JAMA Dermatol; 2014 Dec; 150(12):1345-9. PubMed ID: 25317746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.